SG11202101499UA - Heterocyclic compounds as ahr modulators - Google Patents
Heterocyclic compounds as ahr modulatorsInfo
- Publication number
- SG11202101499UA SG11202101499UA SG11202101499UA SG11202101499UA SG11202101499UA SG 11202101499U A SG11202101499U A SG 11202101499UA SG 11202101499U A SG11202101499U A SG 11202101499UA SG 11202101499U A SG11202101499U A SG 11202101499UA SG 11202101499U A SG11202101499U A SG 11202101499UA
- Authority
- SG
- Singapore
- Prior art keywords
- heterocyclic compounds
- ahr modulators
- ahr
- modulators
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201807515T | 2018-08-31 | ||
| PCT/EP2019/073218 WO2020043880A1 (en) | 2018-08-31 | 2019-08-30 | Heterocyclic compounds as ahr modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202101499UA true SG11202101499UA (en) | 2021-03-30 |
Family
ID=67982014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202101499UA SG11202101499UA (en) | 2018-08-31 | 2019-08-30 | Heterocyclic compounds as ahr modulators |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210395242A1 (en) |
| EP (1) | EP3843853A1 (en) |
| KR (1) | KR20210053911A (en) |
| AU (1) | AU2019331665A1 (en) |
| SG (1) | SG11202101499UA (en) |
| WO (1) | WO2020043880A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3715471A1 (en) | 2019-03-29 | 2020-09-30 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Ahr signature marker set |
| EP3721894A1 (en) | 2019-04-10 | 2020-10-14 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Interleukin-4-induced gene 1 (il4i1) as a biomarker and uses thereof |
| EP3835432A1 (en) | 2019-12-10 | 2021-06-16 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Interleukin-4-induced gene 1 (il4i1) and respective metabolites as biomarkers for cancer |
| WO2021173082A1 (en) | 2020-02-26 | 2021-09-02 | Jaguahr Therapeutics Pte Ltd | Pyridopyrimidine derivatives useful in modulation of ahr signalling |
| WO2024076300A1 (en) | 2022-10-03 | 2024-04-11 | Jaguahr Therapeutics Pte Ltd | Compounds useful in modulation of ahr signalling |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| WO2004012736A1 (en) * | 2002-08-02 | 2004-02-12 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
| WO2005030206A1 (en) * | 2003-09-24 | 2005-04-07 | Imclone Systems Incorporated | Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity |
| WO2009049421A1 (en) * | 2007-10-18 | 2009-04-23 | The Hospital For Sick Children | Compositions and methods for enhancing enzyme activity in gaucher, gm1-gangliosidosis/morquio b disease, and parkinson's disease |
| PE20100362A1 (en) | 2008-10-30 | 2010-05-27 | Irm Llc | PURINE DERIVATIVES THAT EXPAND HEMATOPOYETIC STEM CELLS |
| US10314810B2 (en) | 2010-07-27 | 2019-06-11 | Trustees Of Boston University | Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics |
| PE20190509A1 (en) | 2016-05-25 | 2019-04-10 | Bayer Pharma AG | 3-OXO-2,6-DIFENIL-2,3-DIHIDROPIRIDAZIN-4-CARBOXAMIDS |
| EP3475284B1 (en) * | 2016-06-24 | 2022-11-02 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepines and conjugates thereof |
| TW201835070A (en) * | 2017-02-21 | 2018-10-01 | 德商菲尼克斯製藥股份有限公司 | ARYL HYDROCARBON RECEPTOR (AhR) MODULATOR COMPOUNDS |
| US11548867B2 (en) * | 2017-07-19 | 2023-01-10 | Idea Ya Biosciences, Inc. | Amido compounds as AhR modulators |
| JP2021506883A (en) * | 2017-12-21 | 2021-02-22 | メルサナ セラピューティクス インコーポレイテッド | Pyrrolobenzodiazepine antibody conjugate |
-
2019
- 2019-08-30 AU AU2019331665A patent/AU2019331665A1/en not_active Abandoned
- 2019-08-30 KR KR1020217007908A patent/KR20210053911A/en unknown
- 2019-08-30 WO PCT/EP2019/073218 patent/WO2020043880A1/en unknown
- 2019-08-30 SG SG11202101499UA patent/SG11202101499UA/en unknown
- 2019-08-30 EP EP19769388.0A patent/EP3843853A1/en active Pending
- 2019-08-30 US US17/272,299 patent/US20210395242A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210395242A1 (en) | 2021-12-23 |
| KR20210053911A (en) | 2021-05-12 |
| EP3843853A1 (en) | 2021-07-07 |
| WO2020043880A1 (en) | 2020-03-05 |
| AU2019331665A1 (en) | 2021-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277539A (en) | Heterocyclic compounds as immunomodulators | |
| IL283333A (en) | New heterocyclic compounds | |
| IL273428A (en) | Heterocyclic compounds as pad inhibitors | |
| IL281023A (en) | Tetrahydropyridopyrimidine derivatives as ahr modulators | |
| IL292156A (en) | Substituted azacyles as trmp8 modulators | |
| IL280821A (en) | Heterocyclic compound | |
| SG11202101499UA (en) | Heterocyclic compounds as ahr modulators | |
| SG11202013016YA (en) | Heterocyclic compounds as trk inhibitors | |
| IL289617A (en) | Heterocyclic compounds | |
| IL289595A (en) | Heterocyclic compounds | |
| IL282659A (en) | Heterocyclic compounds as bet inhibitors | |
| ZA202104402B (en) | Heterocyclic compound | |
| IL288987A (en) | New heterocyclic compounds | |
| EP3660003C0 (en) | Heterocyclic compound | |
| EP3693360C0 (en) | Heterocyclic compounds | |
| EP3693368C0 (en) | Heterocyclic compound | |
| IL274821A (en) | Compounds as mpges-1 inhibitors | |
| SG11202009356RA (en) | Heterocyclic compound | |
| IL273237A (en) | Novel heterocyclic compounds as modulators of mglur7 | |
| GB201915191D0 (en) | Novel heterocyclic compounds | |
| ZA201907792B (en) | Heterocyclic compound | |
| IL277340A (en) | Heterocyclic compound | |
| GB201808580D0 (en) | Heterocyclic compounds | |
| GB201806488D0 (en) | Heterocyclic TADF compounds |